All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @officialcorimiles on TikTok · 8s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @officialcorimiles's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Tuck the drugs and the drugs are working.

@officialcorimiles's semaglutide depression claims, fact-checked

CoriMiles

TikTok creator

303.8K viewsWatch on TikTok

Quick answer

Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite through hypothalamic pathways. The STEP 1 trial showed 14.9% weight loss at 68 weeks with 2.4mg weekly dosing. It's not FDA-approved for depression or mood disorders.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @officialcorimiles's semaglutide depression claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@officialcorimiles's semaglutide depression claims, fact-checked" from CoriMiles. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite through hypothalamic pathways.

The reason this review is not generic is the source wording and the canonical claim label "glp1 the stigma sucks but semaglutide gave me my life back this." In this clip, the useful excerpt is: "Tuck the drugs and the drugs are working." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

No clinical trials have tested semaglutide specifically for depression or postpartum depression
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite through hypothalamic pathways.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite through hypothalamic pathways. The STEP 1 trial showed 14.9% weight loss at 68 weeks with 2.4mg weekly dosing. It's not FDA-approved for depression or mood disorders.
  • STEP 1 trial participants lost 14.9% of body weight with 2.4mg weekly semaglutide versus 2.4% with lifestyle changes alone
  • No clinical trials have tested semaglutide specifically for depression or postpartum depression

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • STEP 1 trial participants lost 14.9% of body weight with 2.4mg weekly semaglutide versus 2.4% with lifestyle changes alone
  • No clinical trials have tested semaglutide specifically for depression or postpartum depression
  • STEP trial participants did report improved quality of life and self-esteem as secondary outcomes
  • About 7% of STEP 1 participants stopped semaglutide due to gastrointestinal side effects
  • Postpartum depression affects 10-15% of new mothers and typically requires specialized psychiatric treatment
  • Weight loss through any method can improve mood in some people, but this doesn't make weight loss drugs antidepressants
  • Supervised exercise programs have shown antidepressant effects in clinical trials, but casual gym advice isn't equivalent to structured treatment

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

CoriMiles says semaglutide helped her postpartum depression and got her "off the couch" by making her feel more comfortable in her body. She's pushing back against people who tell her she should've just gone to the gym instead.

The creator frames this as a mental health intervention, not a cosmetic choice. She's also promoting LifeSculpt, though the caption cuts off mid-sentence.

Does semaglutide actually help depression?

There's no direct evidence that semaglutide treats depression as a primary indication. The FDA approved it for type 2 diabetes (as Ozempic) and chronic weight management (as Wegovy), not mood disorders.

However, the STEP 1 trial (Wilding et al., NEJM, 2021) did track quality of life measures. Participants on 2.4mg semaglutide reported improved physical functioning and self-esteem compared to placebo. The STEP 4 trial showed similar mood improvements, but these were secondary outcomes in people losing significant weight.

Weight loss itself can improve depressive symptoms in some people. A 2014 meta-analysis (Fabricatore et al.) found that bariatric surgery patients often see mood improvements alongside weight reduction. But that doesn't make weight loss drugs antidepressants.

What's the connection between postpartum depression and weight?

CoriMiles mentions postpartum depression specifically, which affects 10-15% of new mothers according to ACOG data. The relationship between PPD and weight is complex.

Some women gain weight during PPD episodes due to hormonal changes, sleep disruption, and reduced activity. Others lose weight from loss of appetite. But PPD is a serious mood disorder that typically requires therapy, medication, or both.

No clinical trials have tested semaglutide specifically for postpartum depression. The STEP trials excluded people with major depressive episodes, so we don't have safety data for this population.

Is she wrong about the gym alternative?

CoriMiles is right that "just go to the gym" isn't helpful advice for someone with depression. Exercise can help mood, but telling depressed people to work out misses the point.

The STRIDE trial (Blumenthal et al., 2007) found that supervised exercise helped depression as much as medication in some patients. But that was structured, supervised treatment, not casual gym advice from internet commenters.

For weight loss specifically, the STEP 1 participants who got semaglutide plus lifestyle counseling lost 14.9% of body weight. The lifestyle-only group lost 2.4%. So she's correct that medication can be more effective than exercise alone for significant weight reduction.

What should you actually know?

Semaglutide can cause substantial weight loss, and weight loss may improve some people's mood and self-esteem. But it's not a depression treatment.

The drug works by slowing gastric emptying and affecting brain appetite centers. Common side effects include nausea, vomiting, and diarrhea. About 7% of STEP 1 participants stopped treatment due to gastrointestinal issues.

If you have postpartum depression, talk to a psychiatrist or your OB-GYN about evidence-based treatments. Weight management might be part of your overall care, but it shouldn't replace proper PPD treatment.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

CoriMiles · TikTok creator

303.8K views on this video

The stigma sucks but semaglutide gave me my life back. This wasnt about looks for me. It was about getting my mental health back. I felt so heavy inside of my mind, I couldnt get off the couch (ppd su

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about step 1 trial participants lost 14.9% of body weight with?

STEP 1 trial participants lost 14.9% of body weight with 2.4mg weekly semaglutide versus 2.4% with lifestyle changes alone

What does the video say about no clinical trials have tested semaglutide specifically for depression?

No clinical trials have tested semaglutide specifically for depression or postpartum depression

What does the video say about step trial participants did report improved quality of life?

STEP trial participants did report improved quality of life and self-esteem as secondary outcomes

What does the video say about about 7% of step 1 participants stopped semaglutide due to?

About 7% of STEP 1 participants stopped semaglutide due to gastrointestinal side effects

What does the video say about postpartum depression affects 10-15% of new mothers?

Postpartum depression affects 10-15% of new mothers and typically requires specialized psychiatric treatment

What does the video say about weight loss through any method can improve mood in some?

Weight loss through any method can improve mood in some people, but this doesn't make weight loss drugs antidepressants

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by CoriMiles, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.